Abstract
The past decade brought the beginnings of a renaissance in research on psychedelic drugs. Two articles in this issue of Biological Psychiatry signify that the resurrection of this long-ignored topic has begun to mature and bear at least the promise of fruit. In the early 1970s, the onset of the “War on Drugs” brought with it a near-total hiatus in serious research on psychedelic drugs, especially in the United States. The resumption of credible work in this area has come from Switzerland, where many of the original pioneering studies were initiated in the 1950s and 1960s.
Geyer, M. A. (2015). Lysergic Acid Diethylamide and Psilocybin Revisited. Biological psychiatry, 78(8), 516-518. http://dx.doi.org/10.1016/j.biopsych.2015.08.003
Link to full text
